Literature DB >> 28683286

Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity Susceptibility.

Martin Valdearcos1, John D Douglass2, Megan M Robblee1, Mauricio D Dorfman2, Daniel R Stifler1, Mariko L Bennett3, Irene Gerritse4, Rachael Fasnacht2, Ben A Barres3, Joshua P Thaler5, Suneil K Koliwad6.   

Abstract

Dietary excess triggers accumulation of pro-inflammatory microglia in the mediobasal hypothalamus (MBH), but the components of this microgliosis and its metabolic consequences remain uncertain. Here, we show that microglial inflammatory signaling determines the immunologic response of the MBH to dietary excess and regulates hypothalamic control of energy homeostasis in mice. Either pharmacologically depleting microglia or selectively restraining microglial NF-κB-dependent signaling sharply reduced microgliosis, an effect that includes prevention of MBH entry by bone-marrow-derived myeloid cells, and greatly limited diet-induced hyperphagia and weight gain. Conversely, forcing microglial activation through cell-specific deletion of the negative NF-κB regulator A20 induced spontaneous MBH microgliosis and cellular infiltration, reduced energy expenditure, and increased both food intake and weight gain even in absence of a dietary challenge. Thus, microglial inflammatory activation, stimulated by dietary excess, orchestrates a multicellular hypothalamic response that mediates obesity susceptibility, providing a mechanistic rationale for non-neuronal approaches to treat metabolic diseases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  energy balance; gliosis; hypothalamus; infiltration; inflammation; microglia; myeloid cell; obesity

Mesh:

Substances:

Year:  2017        PMID: 28683286      PMCID: PMC5569901          DOI: 10.1016/j.cmet.2017.05.015

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  58 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice.

Authors:  Xiaomei Feng; Martin Valdearcos; Yosuke Uchida; David Lutrin; Mervyn Maze; Suneil K Koliwad
Journal:  JCI Insight       Date:  2017-04-06

3.  IKK-beta links inflammation to obesity-induced insulin resistance.

Authors:  Melek C Arkan; Andrea L Hevener; Florian R Greten; Shin Maeda; Zhi-Wei Li; Jeffrey M Long; Anthony Wynshaw-Boris; Giuseppe Poli; Jerrold Olefsky; Michael Karin
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

4.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

Authors:  Rita M Tavares; Emre E Turer; Chih L Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A Lowell; Paul J Utz; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2010-08-12       Impact factor: 31.745

5.  Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance.

Authors:  Louise E Olofsson; Elizabeth K Unger; Clement C Cheung; Allison W Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

6.  Isolation of murine microglial cells for RNA analysis or flow cytometry.

Authors:  Astrid E Cardona; DeRen Huang; Margaret E Sasse; Richard M Ransohoff
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

7.  Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

Authors:  Christopher N Parkhurst; Guang Yang; Ipe Ninan; Jeffrey N Savas; John R Yates; Juan J Lafaille; Barbara L Hempstead; Dan R Littman; Wen-Biao Gan
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

8.  Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

Authors:  Oleg Butovsky; Shafiuddin Siddiqui; Galina Gabriely; Amanda J Lanser; Ben Dake; Gopal Murugaiyan; Camille E Doykan; Pauline M Wu; Reddy R Gali; Lakshmanan K Iyer; Robert Lawson; James Berry; Anna M Krichevsky; Merit E Cudkowicz; Howard L Weiner
Journal:  J Clin Invest       Date:  2012-08-06       Impact factor: 14.808

9.  Hormones and diet, but not body weight, control hypothalamic microglial activity.

Authors:  Yuanqing Gao; Nickki Ottaway; Sonja C Schriever; Beata Legutko; Cristina García-Cáceres; Esther de la Fuente; Clarita Mergen; Susanne Bour; Joshua P Thaler; Randy J Seeley; Jessica Filosa; Javier E Stern; Diego Perez-Tilve; Michael W Schwartz; Matthias H Tschöp; Chun-Xia Yi
Journal:  Glia       Date:  2013-10-28       Impact factor: 7.452

10.  Radiologic evidence that hypothalamic gliosis is associated with obesity and insulin resistance in humans.

Authors:  Ellen A Schur; Susan J Melhorn; Seok-Kyun Oh; J Matthew Lacy; Kathryn E Berkseth; Stephan J Guyenet; Joshua A Sonnen; Vidhi Tyagi; Mary Rosalynn; B De Leon; Mary F Webb; Zenobia T Gonsalves; Corinne L Fligner; Michael W Schwartz; Kenneth R Maravilla
Journal:  Obesity (Silver Spring)       Date:  2015-11       Impact factor: 5.002

View more
  132 in total

1.  Initial evidence for hypothalamic gliosis in children with obesity by quantitative T2 MRI and implications for blood oxygen-level dependent response to glucose ingestion.

Authors:  Leticia E Sewaybricker; Ellen A Schur; Susan J Melhorn; Brunno M Campos; Mary K Askren; Guilherme A S Nogueira; Mariana P Zambon; Maria Angela R G M Antonio; Fernando Cendes; Licio A Velloso; Gil Guerra-Junior
Journal:  Pediatr Obes       Date:  2018-12-10       Impact factor: 4.000

2.  Sex-specific brain erythropoietin regulation of mouse metabolism and hypothalamic inflammation.

Authors:  Soumyadeep Dey; Zhenzhong Cui; Oksana Gavrilova; Xiaojie Zhang; Max Gassmann; Constance T Noguchi
Journal:  JCI Insight       Date:  2020-03-12

Review 3.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 4.  Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus.

Authors:  Adilson Guilherme; Felipe Henriques; Alexander H Bedard; Michael P Czech
Journal:  Nat Rev Endocrinol       Date:  2019-04       Impact factor: 43.330

5.  Reversal of a Treatment-Resistant, Depression-Related Brain State with the Kv7 Channel Opener Retigabine.

Authors:  Mengyang Feng; Nicole A Crowley; Akshilkumar Patel; Yao Guo; Sierra E Bugni; Bernhard Luscher
Journal:  Neuroscience       Date:  2019-03-08       Impact factor: 3.590

6.  Associations Between Body Weight, Hippocampal Volume, and Tissue Signal Intensity in 12- to 18-Year-Olds.

Authors:  Zoe Mestre; Amanda Bischoff-Grethe; Christina E Wierenga; Terry Jernigan; Dawn M Eichen; Linda Chang; Thomas Ernst; Kerri N Boutelle
Journal:  Obesity (Silver Spring)       Date:  2020-06-05       Impact factor: 5.002

Review 7.  A20: A multifunctional tool for regulating immunity and preventing disease.

Authors:  Barbara A Malynn; Averil Ma
Journal:  Cell Immunol       Date:  2019-04-05       Impact factor: 4.868

Review 8.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

9.  Magnetic resonance assessment of the cerebral alterations associated with obesity development.

Authors:  Blanca Lizarbe; Basilio Campillo; Irene Guadilla; Pilar López-Larrubia; Sebastián Cerdán
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-23       Impact factor: 6.200

10.  Reversal of prolonged obesity-associated cerebrovascular dysfunction by inhibiting microglial Tak1.

Authors:  Qing Shen; Zhuo Chen; Faming Zhao; Susu Pan; Tingting Zhang; Xueer Cheng; Lei Zhang; Shanshan Zhang; Junxia Qi; Juxue Li; Dongsheng Cai; Guo Zhang
Journal:  Nat Neurosci       Date:  2020-05-25       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.